2026-10-25
iShares MSCI ACWI Low Carbon Target ETF is only partially screened so far, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 29,813 +0.55%
S&P 7,744 +0.28%
GOLD $4,041 −0.27%
BTC $80,068 −1.48%
VIX 17.02 +0.65%
latest tape · as of 10:09 UTC
The Screen · ETF
iShares MSCI ACWI Low Carbon Target ETF
CRBN · NYSE ARCA · USD
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securi…
Not yet scored251.98 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago
Screened 2026-10-23 · the tape above runs as of 10:09 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price251.98 USD at the 23 Oct 2026 close
- Our ratingOvervalued, current read markdown
- Ethical screenNot yet scored
- Last reviewed23 Oct 2026 (6 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 251.98 against the desk's fair-value range, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Price251.98 USD
Ethical score30.0/100
RatingOVERVALUED
Our investment reviews on this name
2026-10-21Read Markdown256.34-1.7% to today ✓Accumulation gives way to Markdown
2026-10-11Read Accumulation260.38-3.2% to today Distribution gives way to Accumulation
2026-10-02Read Distribution260.38-3.2% to today ✓Markup gives way to Distribution
2026-07-02Read Markup251.08+0.4% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markdown label.
iShares MSCI ACWI Low Carbon Target ETF holds its Markdown at $251.98. The statistical read favours the sellers, held for 1 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 1 days |
| Price at the screen | $251.98 |
| Valuation | 22.20 trailing · N/A forward price to earnings |
| Values screen | Not scored · score 30.0 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Not a Shariah-screened or physical-metal instrument: needs a real screen | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
iShares MSCI ACWI Low Carbon Target ETF is only partially screened so far, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
iShares MSCI ACWI Low Carbon Target ETF clears all five screens. Its business is in a permissible area, its debt, cash, receivables and income are all inside the lines, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads OVERVALUED
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Trailing P/E | 22.2xa premium valuation |
| Dividend yield | 199.00% |
| 52-week range | 209.85 - 257.83 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCRBN trades on NYSE ARCA. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-21
Markdown · changed $256.34
-1.6% Entry 8
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 8%.
2026-10-11
Accumulation · changed $260.38
+0.0% Entry 7
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 8%.
2026-10-02
Distribution · changed $260.38
+4.2% Entry 6
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 4.2% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 8%.
2026-08-25
Markup $249.85
+0.0% Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 8%.
2026-07-25
Markup $249.85
-0.5% Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.5% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 8%.
2026-07-18
Markup $251.08
+0.0% Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 8%.
2026-07-03
Markup $251.08
+0.0% Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02
Markup $251.08
Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Is iShares Low Carbon Optimized MSCI ACWI ETF (CRBN) a Strong ETF Right Now? Zacks · 20 Aug 2026
- Is iShares Low Carbon Optimized MSCI ACWI ETF (CRBN) a Strong ETF Right Now? Yahoo Finance · 20 Aug 2026
- Corbion announces organic sales growth of +8.5% to €337.4m and Adjusted EBITDA of €51.0m in Q2; refines full-year margin outlook to >16% Yahoo Finance · 31 Jul 2026
- Chair of the Supervisory Board of Corbion to step down as of 1 August 2026 Yahoo Finance · 4 Jun 2026
- Assessing Corbion (ENXTAM:CRBN) Valuation After Prolonged Weak Shareholder Returns Simply Wall St. · 3 Apr 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $250.67 | -1.6% | · | $984 | -1.6% |
| 2 months | $233.18 | +5.7% | · | $1,057 | +5.7% |
| 3 months | $226.89 | +8.7% | · | $1,087 | +8.7% |
| 6 months | $230.41 | +7.0% | $3.38 | $1,085 | +8.5% |
| 1 year | $203.21 | +21.3% | $5.09 | $1,238 | +23.8% |
| 2 years | $175.25 | +40.7% | $8.84 | $1,457 | +45.7% |
| 3 years | $144.28 | +70.9% | $10.68 | $1,783 | +78.3% |
| 5 years | $151.63 | +62.6% | $16.44 | $1,735 | +73.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CRBN does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.